Tapewire

Nasdaq · USD

XNCR

Xencor Inc

Export transactions ↓
Tapewire entity
4487
SEC CIK
0001326732
Parsed reports
264

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202600
Mar 2026010
Apr 202601
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 17, 2018 Filed Sep 18, 2018 20:28 UTC
Foster Paul AChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-051472 · doc4.xml · derivative · entry 3

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 40,000 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
September 17, 2018 Filed Sep 18, 2018 20:28 UTC
Foster Paul AChief Medical Officer
SaleCommon Stock 40,000 $46.03 $1,841,208.00
Disclosure

SEC source: 0001209191-18-051472 · doc4.xml · nonDerivative · entry 2

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,952

F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 17, 2018.

F2 · price: The weighted average sale price for the transaction reported was $46.0302, and the range of prices were between $46.0121 and $46.0782. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Read SEC document
September 17, 2018 Filed Sep 18, 2018 20:28 UTC
Foster Paul AChief Medical Officer
Exercise / conversionCommon Stock 40,000 $11.05 $442,000.00
Disclosure

SEC source: 0001209191-18-051472 · doc4.xml · nonDerivative · entry 1

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 17, 2018.

Read SEC document
September 14, 2018 Filed Sep 18, 2018 20:04 UTC SaleCommon Stock 1,000 $48.05 $48,054.00
Disclosure

SEC source: 0001179110-18-011490 · edgar.xml · nonDerivative · entry 1

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,017,848

F1 · price: This transaction was executed in multiple trades at prices ranging from $48.05 to $48.06. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
August 17, 2018 Filed Aug 17, 2018 22:20 UTC
Foster Paul AChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,659 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-047522 · doc4.xml · derivative · entry 3

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 3,659 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
August 17, 2018 Filed Aug 17, 2018 22:20 UTC
Foster Paul AChief Medical Officer
SaleCommon Stock 3,659 $40.10 $146,725.90
Disclosure

SEC source: 0001209191-18-047522 · doc4.xml · nonDerivative · entry 2

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,952

Read SEC document
August 17, 2018 Filed Aug 17, 2018 22:20 UTC
Foster Paul AChief Medical Officer
Exercise / conversionCommon Stock 3,659 $11.05 $40,431.95
Disclosure

SEC source: 0001209191-18-047522 · doc4.xml · nonDerivative · entry 1

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 20,739 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · derivative · entry 9

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,659

Underlying: Common Stock · 20,739 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
August 16, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
SaleCommon Stock 20,739 $41.10 $852,372.90
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 6

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,952

Read SEC document
August 16, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
Exercise / conversionCommon Stock 20,739 $11.05 $229,165.95
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 5

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 106 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · derivative · entry 8

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,398

Underlying: Common Stock · 106 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
August 15, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
SaleCommon Stock 106 $41.10 $4,356.60
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 4

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,952

Read SEC document
August 15, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
Exercise / conversionCommon Stock 106 $11.05 $1,171.30
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 3

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,058

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 14, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 15,496 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · derivative · entry 7

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,504

Underlying: Common Stock · 15,496 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
August 14, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
SaleCommon Stock 15,496 $41.11 $636,980.13
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 2

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,952

F2 · price: The weighted average sale price for the transaction reported was $41.1061, and the range of prices were between $41.10 and $41.120. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Read SEC document
August 14, 2018 Filed Aug 16, 2018 23:31 UTC
Foster Paul AChief Medical Officer
Exercise / conversionCommon Stock 15,496 $11.05 $171,230.80
Disclosure

SEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 1

Foster Paul A · CIK 0001591213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,207 shares of Common Stock acquired on June 10, 2015, 1,212 shares of Common Stock acquired on December 10, 2015 and 114 shares of Common Stock acquired on June 9, 2018.

Read SEC document
August 13, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
Exercise / conversionStock Option (right to buy) · Derivative 12,734 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · derivative · entry 7

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,734 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
August 13, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
SaleCommon Stock 12,734 $40.35 $513,874.20
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · nonDerivative · entry 5

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.30 to $40.355, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 13, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
Exercise / conversionCommon Stock 12,734 $11.05 $140,710.70
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · nonDerivative · entry 4

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 10, 2018 Filed Aug 10, 2018 22:36 UTC
Desjarlais John RSr. V.P., Research & CSO
SaleCommon Stock 14,867 $40.03 $595,091.82
Disclosure

SEC source: 0001209191-18-046308 · doc4.xml · nonDerivative · entry 3

Desjarlais John R · CIK 0001591313 · Sr. V.P., Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,098

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.0558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 10, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
SaleCommon Stock 28,983 $40.03 $1,160,044.58
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · nonDerivative · entry 3

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.0558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 09, 2018 Filed Aug 10, 2018 22:36 UTC
Desjarlais John RSr. V.P., Research & CSO
Exercise / conversionStock Option (right to buy) · Derivative 35,000 $0.00 Strike: $4.25 $0.00
Disclosure

SEC source: 0001209191-18-046308 · doc4.xml · derivative · entry 4

Desjarlais John R · CIK 0001591313 · Sr. V.P., Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,522

Underlying: Common Stock · 35,000 shares

Expires 2023-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
August 09, 2018 Filed Aug 10, 2018 22:36 UTC
Desjarlais John RSr. V.P., Research & CSO
SaleCommon Stock 20,133 $40.61 $817,629.32
Disclosure

SEC source: 0001209191-18-046308 · doc4.xml · nonDerivative · entry 2

Desjarlais John R · CIK 0001591313 · Sr. V.P., Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,965

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.77 to $42.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 09, 2018 Filed Aug 10, 2018 22:36 UTC
Desjarlais John RSr. V.P., Research & CSO
Exercise / conversionCommon Stock 35,000 $4.25 $148,750.00
Disclosure

SEC source: 0001209191-18-046308 · doc4.xml · nonDerivative · entry 1

Desjarlais John R · CIK 0001591313 · Sr. V.P., Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,098

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 156 shares of Common Stock acquired on June 19, 2017, 159 shares of Common Stock acquired on December 10, 2017 and 107 shares of Common Stock acquired on June 8, 2018.

Read SEC document
August 09, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
Exercise / conversionStock Option (right to buy) · Derivative 37,266 $0.00 Strike: $11.05 $0.00
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · derivative · entry 6

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,734

Underlying: Common Stock · 37,266 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
August 09, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
SaleCommon Stock 8,283 $40.35 $334,198.34
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · nonDerivative · entry 2

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,190

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 09, 2018 Filed Aug 13, 2018 19:59 UTC
Baracchini Edgardo JrChief Business Officer
Exercise / conversionCommon Stock 37,266 $11.05 $411,789.30
Disclosure

SEC source: 0001209191-18-046514 · doc4.xml · nonDerivative · entry 1

Baracchini Edgardo Jr · CIK 0001291972 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 207 shares of Common Stock that were acquired by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
July 17, 2018 Filed Jul 17, 2018 20:08 UTC SaleCommon Stock 36,500 $41.24 $1,505,260.00
Disclosure

SEC source: 0001179110-18-009739 · edgar.xml · nonDerivative · entry 3

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,018,848

F3 · price: This transaction was executed in multiple trades at prices ranging from $40.85 to $41.57. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:08 UTC SaleCommon Stock 26,888 $40.67 $1,093,534.96
Disclosure

SEC source: 0001179110-18-009739 · edgar.xml · nonDerivative · entry 2

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,055,348

F2 · price: This transaction was executed in multiple trades at prices ranging from $40.25 to $41.50. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
July 13, 2018 Filed Jul 17, 2018 20:08 UTC SaleCommon Stock 48,312 $41.97 $2,027,683.63
Disclosure

SEC source: 0001179110-18-009739 · edgar.xml · nonDerivative · entry 1

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,082,236

F1 · price: This transaction was executed in multiple trades at prices ranging from $41.87 to $42.08. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
July 12, 2018 Filed Jul 12, 2018 21:26 UTC SaleCommon Stock 58,000 $39.55 $2,293,900.00
Disclosure

SEC source: 0001179110-18-009648 · edgar.xml · nonDerivative · entry 5

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,130,548

F4 · price: This transaction was executed in multiple trades at prices ranging from $39.38 to $39.80. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected

Read SEC document
July 11, 2018 Filed Jul 12, 2018 21:26 UTC SaleCommon Stock 30,007 $39.63 $1,189,177.41
Disclosure

SEC source: 0001179110-18-009648 · edgar.xml · nonDerivative · entry 4

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,188,548

F3 · price: This transaction was executed in multiple trades at prices ranging from $39.44 to $39.79. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
July 10, 2018 Filed Jul 12, 2018 21:26 UTC SaleCommon Stock 50,293 $39.89 $2,006,187.77
Disclosure

SEC source: 0001179110-18-009648 · edgar.xml · nonDerivative · entry 3

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,218,555

F2 · price: This transaction was executed in multiple trades at prices ranging from $39.59 to $40.14. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
June 27, 2018 Filed Jul 12, 2018 21:26 UTC GiftCommon Stock 7,500 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-009648 · edgar.xml · nonDerivative · entry 2

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,268,848

F1 · kind: On June 27, 2018, the reporting person transferred 7,500 shares of common stock for no consideration to his class C capital account at Ronin Capital, LLC.

F1 · price: On June 27, 2018, the reporting person transferred 7,500 shares of common stock for no consideration to his class C capital account at Ronin Capital, LLC.

Read SEC document
June 27, 2018 Filed Jul 12, 2018 21:26 UTC GiftCommon Stock 7,500 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-009648 · edgar.xml · nonDerivative · entry 1

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On June 27, 2018, the reporting person transferred 7,500 shares of common stock for no consideration to his class C capital account at Ronin Capital, LLC.

F1 · price: On June 27, 2018, the reporting person transferred 7,500 shares of common stock for no consideration to his class C capital account at Ronin Capital, LLC.

Read SEC document
June 26, 2018 Filed Jun 27, 2018 18:03 UTC GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $38.93 $0.00
Disclosure

SEC source: 0001209191-18-039699 · doc4.xml · derivative · entry 1

Hata Yujiro S · CIK 0001649119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2028-06-25

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2018, such that the total number of shares will be fully vested on June 26, 2019.

Read SEC document
June 26, 2018 Filed Jun 27, 2018 22:09 UTC GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $38.93 $0.00
Disclosure

SEC source: 0001209191-18-039701 · doc4.xml · derivative · entry 1

GUSTAFSON KURT A · CIK 0001462354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2028-06-25

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2018, such that the total number of shares will be fully vested on June 26, 2019.

Read SEC document
June 26, 2018 Filed Jun 27, 2018 22:01 UTC GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $38.93 $0.00
Disclosure

SEC source: 0001209191-18-039698 · doc4.xml · derivative · entry 1

GORMAN KEVIN CHARLES · CIK 0001201096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2028-06-25

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2018, such that the total number of shares will be fully vested on June 26, 2019.

Read SEC document
June 26, 2018 Filed Jun 27, 2018 22:07 UTC GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $38.93 $0.00
Disclosure

SEC source: 0001209191-18-039700 · doc4.xml · derivative · entry 1

RANIERI RICHARD J · CIK 0001225617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2028-06-25

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2018, such that the total number of shares will be fully vested on June 26, 2019.

Read SEC document
June 26, 2018 Filed Jun 27, 2018 21:59 UTC GrantStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $38.93 $0.00
Disclosure

SEC source: 0001209191-18-039697 · doc4.xml · derivative · entry 1

Montgomery Alan Bruce · CIK 0001313936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2028-06-25

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2018, such that the total number of shares will be fully vested on June 26, 2019.

Read SEC document
June 20, 2018 Filed Jun 20, 2018 20:28 UTC SaleCommon Stock 92,779 $40.05 $3,715,798.95
Disclosure

SEC source: 0001179110-18-008826 · edgar.xml · nonDerivative · entry 3

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,261,348

F3 · price: This transaction was executed in multiple trades at prices ranging from $39.75 to $40.34. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
June 19, 2018 Filed Jun 20, 2018 20:28 UTC SaleCommon Stock 103,454 $39.77 $4,114,365.58
Disclosure

SEC source: 0001179110-18-008826 · edgar.xml · nonDerivative · entry 2

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,354,127

F2 · price: This transaction was executed in multiple trades at prices ranging from $39.62 to $39.97. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
June 18, 2018 Filed Jun 20, 2018 20:28 UTC SaleCommon Stock 53,767 $39.88 $2,144,227.96
Disclosure

SEC source: 0001179110-18-008826 · edgar.xml · nonDerivative · entry 1

STAFFORD JOHN S III · CIK 0001218981 · 10% owner

Ronin Capital, LLC · CIK 0001512282 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ronin Capital, LLC

Disclosed balance after: 5,457,581

F1 · price: This transaction was executed in multiple trades at prices ranging from $39.70 to $40.10. The price reported above reflects the average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
June 15, 2018 Filed Jun 16, 2018 00:11 UTC
Dahiyat Bassil IDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.25 $0.00
Disclosure

SEC source: 0001209191-18-038211 · doc4.xml · derivative · entry 3

Dahiyat Bassil I · CIK 0001591312 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,024

Underlying: Common Stock · 50,000 shares

Expires 2023-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
June 15, 2018 Filed Jun 16, 2018 00:11 UTC
Dahiyat Bassil IDirector · President and CEO
Exercise / conversionCommon Stock 50,000 $4.25 $212,500.00
Disclosure

SEC source: 0001209191-18-038211 · doc4.xml · nonDerivative · entry 2

Dahiyat Bassil I · CIK 0001591312 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2018 Filed Jun 16, 2018 00:11 UTC
Dahiyat Bassil IDirector · President and CEO
SaleCommon Stock 50,000 $40.51 $2,025,690.00
Disclosure

SEC source: 0001209191-18-038211 · doc4.xml · nonDerivative · entry 1

Dahiyat Bassil I · CIK 0001591312 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,067

F1 · price: The weighted average sale price for the transaction reported was $40.5138, and the range of prices were between $40.35 and $40.8507. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F2 · balance_after: Includes 388 shares of Common Stock that were acquired by the Reporting Person on June 10, 2016, 399 shares of Common Stock that were acquired by the Reporting Person on December 9, 2016, 429 shares of Common Stock that were acquired by the Reporting Person on June 10, 2017, 436 shares of Common Stock that were acquired by the Reporting Person on December 10, 2017 and 287 shares of Common Stock that were acquired by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 21:35 UTC
Kuch John JSr. Vice President & CFO
Exercise / conversionStock Option (right to buy) · Derivative 35,853 $0.00 Strike: $4.25 $0.00
Disclosure

SEC source: 0001209191-18-038128 · doc4.xml · derivative · entry 3

Kuch John J · CIK 0001591306 · Sr. Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,853 shares

Expires 2023-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 21:35 UTC
Kuch John JSr. Vice President & CFO
Exercise / conversionCommon Stock 35,853 $4.25 $152,375.25
Disclosure

SEC source: 0001209191-18-038128 · doc4.xml · nonDerivative · entry 2

Kuch John J · CIK 0001591306 · Sr. Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 21:35 UTC
Kuch John JSr. Vice President & CFO
SaleCommon Stock 25,000 $41.64 $1,040,945.00
Disclosure

SEC source: 0001209191-18-038128 · doc4.xml · nonDerivative · entry 1

Kuch John J · CIK 0001591306 · Sr. Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,629

F1 · price: The weighted average sale price for the transaction reported was $41.6378, and the range of prices were between $41.50 and $41.965. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F2 · balance_after: Includes 2,084 shares of Common Stock that were acquired by the Reporting Person on June 9, 2017, 1,800 shares of Common Stock that were acquired by the Reporting Person on December 15, 2017 and 574 shares of Common Stock that were acquired by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
May 15, 2018 Filed May 21, 2018 23:11 UTC
Kuch John JSr. Vice President & CFO
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $33.11 $0.00
Disclosure

SEC source: 0001209191-18-032123 · doc4.xml · derivative · entry 1

Kuch John J · CIK 0001591306 · Sr. Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-14

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on the one year anniversary of May 15, 2018 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.